Doxazosin

Product NDC: 50090-0704
11-digit product format: 500900704
Labeler code: 50090
Product ID: 50090-0704_33c2d704-0230-4323-af6a-01c55e6616ed
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Doxazosin
Dosage form: TABLET
Route: ORAL
Labeler: A-S Medication Solutions
Application: ANDA075580
Marketing category: ANDA
Marketing start: 2011-07-14
Marketing end: 0000-00-00
Substance: DOXAZOSIN MESYLATE
Active strength: 2 mg/1
Pharmacologic classes: Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC]
NDC exclude flag: No
Listing certified through: 2022-12-31
Current FDA listing: Historical FDA.report record

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 36 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	50090-0704-0	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	50090-0704-1	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	50090-0704-0	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	50090-0704-1	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	50090-0704-0	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	50090-0704-1	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	50090-0704-0	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	50090-0704-1	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	50090-0704-0	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	50090-0704-1	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	50090-0704-0	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	50090-0704-1	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	50090-0704-0	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	50090-0704-1	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	50090-0704-0	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	50090-0704-1	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	50090-0704-0	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	50090-0704-1	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	50090-0704-0	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	50090-0704-1	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	50090-0704-0	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	50090-0704-1	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	50090-0704-0	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	50090-0704-1	`557ba5c1ecfa…`	`9c80585c8c6e…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 4 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	Approval date
A075580-001	DOXAZOSIN MESYLATE	DOXAZOSIN MESYLATE	EQ 1MG BASE	TABLET / ORAL	AB	2000-10-18
A075580-002	DOXAZOSIN MESYLATE	DOXAZOSIN MESYLATE	EQ 2MG BASE	TABLET / ORAL	AB	2000-10-18
A075580-003	DOXAZOSIN MESYLATE	DOXAZOSIN MESYLATE	EQ 4MG BASE	TABLET / ORAL	AB	2000-10-18
A075580-004	DOXAZOSIN MESYLATE	DOXAZOSIN MESYLATE	EQ 8MG BASE	TABLET / ORAL	AB	2000-10-18

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 4 matching rows.

Application-product, TE code table
Application-product	TE code
A075580-001	AB
A075580-002	AB
A075580-003	AB
A075580-004	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 5 · 164 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A075580-001	DOXAZOSIN MESYLATE	EQ 1MG BASE	TABLET / ORAL	AB	2000-10-18	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A075580-002	DOXAZOSIN MESYLATE	EQ 2MG BASE	TABLET / ORAL	AB	2000-10-18	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A075580-003	DOXAZOSIN MESYLATE	EQ 4MG BASE	TABLET / ORAL	AB	2000-10-18	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A075580-004	DOXAZOSIN MESYLATE	EQ 8MG BASE	TABLET / ORAL	AB	2000-10-18	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A075580-001	DOXAZOSIN MESYLATE	EQ 1MG BASE	TABLET / ORAL	AB	2000-10-18	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A075580-002	DOXAZOSIN MESYLATE	EQ 2MG BASE	TABLET / ORAL	AB	2000-10-18	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A075580-003	DOXAZOSIN MESYLATE	EQ 4MG BASE	TABLET / ORAL	AB	2000-10-18	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A075580-004	DOXAZOSIN MESYLATE	EQ 8MG BASE	TABLET / ORAL	AB	2000-10-18	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A075580-001	DOXAZOSIN MESYLATE	EQ 1MG BASE	TABLET / ORAL	AB	2000-10-18	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A075580-002	DOXAZOSIN MESYLATE	EQ 2MG BASE	TABLET / ORAL	AB	2000-10-18	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A075580-003	DOXAZOSIN MESYLATE	EQ 4MG BASE	TABLET / ORAL	AB	2000-10-18	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A075580-004	DOXAZOSIN MESYLATE	EQ 8MG BASE	TABLET / ORAL	AB	2000-10-18	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A075580-001	DOXAZOSIN MESYLATE	EQ 1MG BASE	TABLET / ORAL	AB	2000-10-18	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A075580-002	DOXAZOSIN MESYLATE	EQ 2MG BASE	TABLET / ORAL	AB	2000-10-18	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A075580-003	DOXAZOSIN MESYLATE	EQ 4MG BASE	TABLET / ORAL	AB	2000-10-18	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A075580-004	DOXAZOSIN MESYLATE	EQ 8MG BASE	TABLET / ORAL	AB	2000-10-18	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A075580-001	DOXAZOSIN MESYLATE	EQ 1MG BASE	TABLET / ORAL	AB	2000-10-18	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A075580-002	DOXAZOSIN MESYLATE	EQ 2MG BASE	TABLET / ORAL	AB	2000-10-18	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A075580-003	DOXAZOSIN MESYLATE	EQ 4MG BASE	TABLET / ORAL	AB	2000-10-18	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A075580-004	DOXAZOSIN MESYLATE	EQ 8MG BASE	TABLET / ORAL	AB	2000-10-18	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A075580-001	DOXAZOSIN MESYLATE	EQ 1MG BASE	TABLET / ORAL	AB	2000-10-18	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A075580-002	DOXAZOSIN MESYLATE	EQ 2MG BASE	TABLET / ORAL	AB	2000-10-18	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A075580-003	DOXAZOSIN MESYLATE	EQ 4MG BASE	TABLET / ORAL	AB	2000-10-18	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A075580-004	DOXAZOSIN MESYLATE	EQ 8MG BASE	TABLET / ORAL	AB	2000-10-18	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A075580-001	DOXAZOSIN MESYLATE	EQ 1MG BASE	TABLET / ORAL	AB	2000-10-18	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A075580-002	DOXAZOSIN MESYLATE	EQ 2MG BASE	TABLET / ORAL	AB	2000-10-18	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A075580-003	DOXAZOSIN MESYLATE	EQ 4MG BASE	TABLET / ORAL	AB	2000-10-18	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A075580-004	DOXAZOSIN MESYLATE	EQ 8MG BASE	TABLET / ORAL	AB	2000-10-18	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A075580-001	DOXAZOSIN MESYLATE	EQ 1MG BASE	TABLET / ORAL	AB	2000-10-18	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A075580-002	DOXAZOSIN MESYLATE	EQ 2MG BASE	TABLET / ORAL	AB	2000-10-18	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A075580-003	DOXAZOSIN MESYLATE	EQ 4MG BASE	TABLET / ORAL	AB	2000-10-18	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A075580-004	DOXAZOSIN MESYLATE	EQ 8MG BASE	TABLET / ORAL	AB	2000-10-18	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A075580-001	DOXAZOSIN MESYLATE	EQ 1MG BASE	TABLET / ORAL	AB	2000-10-18	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A075580-002	DOXAZOSIN MESYLATE	EQ 2MG BASE	TABLET / ORAL	AB	2000-10-18	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A075580-003	DOXAZOSIN MESYLATE	EQ 4MG BASE	TABLET / ORAL	AB	2000-10-18	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A075580-004	DOXAZOSIN MESYLATE	EQ 8MG BASE	TABLET / ORAL	AB	2000-10-18	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A075580-001	DOXAZOSIN MESYLATE	EQ 1MG BASE	TABLET / ORAL	AB	2000-10-18	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A075580-002	DOXAZOSIN MESYLATE	EQ 2MG BASE	TABLET / ORAL	AB	2000-10-18	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A075580-003	DOXAZOSIN MESYLATE	EQ 4MG BASE	TABLET / ORAL	AB	2000-10-18	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A075580-004	DOXAZOSIN MESYLATE	EQ 8MG BASE	TABLET / ORAL	AB	2000-10-18	`d06236e962d9…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 5 · 164 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A075580-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A075580-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A075580-003	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A075580-004	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A075580-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A075580-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A075580-003	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A075580-004	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A075580-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A075580-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A075580-003	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A075580-004	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A075580-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A075580-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A075580-003	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A075580-004	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A075580-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A075580-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A075580-003	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A075580-004	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A075580-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A075580-002	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A075580-003	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A075580-004	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A075580-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A075580-002	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A075580-003	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A075580-004	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A075580-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A075580-002	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A075580-003	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A075580-004	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A075580-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A075580-002	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A075580-003	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A075580-004	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A075580-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A075580-002	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A075580-003	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A075580-004	AB	1	`d06236e962d9…`

Additional Listing Data#

Finished product: Yes
Brand name base: Doxazosin
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
DOXAZOSIN MESYLATE	2 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
86P6PQK0MU	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 4 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
197625	Internal RxNorm lookup
197626	Internal RxNorm lookup
197627	Internal RxNorm lookup
197628	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
bfea0b5b-9354-490f-88ff-008134077d24	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
07a517fc-5845-3816-0f81-0a121804ec9e	Product name	6	20250107
171dd63c-7eea-ede4-c010-4c25ba0a1087	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDC	Effective	Related label
50090-0704-0	2023-02-07	These highlights do not include all the information needed to use DOXAZOSIN TABLETS safely and effectively. See full prescribing information for DOXAZOSIN TABLETS. DOXAZOSIN tablets, for oral use Initial U.S. Approval: 1990
50090-0704-0	2023-02-07	These highlights do not include all the information needed to use DOXAZOSIN TABLETS safely and effectively. See full prescribing information for DOXAZOSIN TABLETS. DOXAZOSIN tablets, for oral use Initial U.S. Approval: 1990
50090-0704-1	2023-02-07	These highlights do not include all the information needed to use DOXAZOSIN TABLETS safely and effectively. See full prescribing information for DOXAZOSIN TABLETS. DOXAZOSIN tablets, for oral use Initial U.S. Approval: 1990
50090-0704-1	2023-02-07	These highlights do not include all the information needed to use DOXAZOSIN TABLETS safely and effectively. See full prescribing information for DOXAZOSIN TABLETS. DOXAZOSIN tablets, for oral use Initial U.S. Approval: 1990
50090-0704-0	2023-01-30	These highlights do not include all the information needed to use DOXAZOSIN TABLETS safely and effectively. See full prescribing information for DOXAZOSIN TABLETS. DOXAZOSIN tablets, for oral use Initial U.S. Approval: 1990
50090-0704-0	2023-01-30	These highlights do not include all the information needed to use DOXAZOSIN TABLETS safely and effectively. See full prescribing information for DOXAZOSIN TABLETS. DOXAZOSIN tablets, for oral use Initial U.S. Approval: 1990
50090-0704-1	2023-01-30	These highlights do not include all the information needed to use DOXAZOSIN TABLETS safely and effectively. See full prescribing information for DOXAZOSIN TABLETS. DOXAZOSIN tablets, for oral use Initial U.S. Approval: 1990
50090-0704-1	2023-01-30	These highlights do not include all the information needed to use DOXAZOSIN TABLETS safely and effectively. See full prescribing information for DOXAZOSIN TABLETS. DOXAZOSIN tablets, for oral use Initial U.S. Approval: 1990

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
50090-0704-0	Doxazosin	30 in 1 BOTTLE	TABLET	30		30
50090-0704-1	Doxazosin	100 in 1 BOTTLE	TABLET	100		30

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
50090-0704-0	EA - Each	50090-0704	666e1dbf-77fa-443e-81e6-dae2c7bd1b19	1	2018-12-13

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
50090-0704	DOXAZOSIN TABLET [A-S MEDICATION SOLUTIONS]	28	Legacy NDC, 2 package rows	20240615_bfea0b5b-9354-490f-88ff-008134077d24.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 20 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Doxazosin	DOXAZOSIN	A-S Medication Solutions	bfea0b5b-9354-490f-88ff-008134077d24	2026-07-16	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075580 application number: ANDA075580 ndc (product): 50090-0704
Doxazosin	DOXAZOSIN	REMEDYREPACK INC.	bf2f7b41-f14d-4fcd-8db3-f507ca6ff78b	2026-06-12	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075580 application number: ANDA075580
Doxazosin	DOXAZOSIN	PD-Rx Pharmaceuticals, Inc.	2ea9bb6b-a4f0-496a-b27b-4454167a4b70	2026-05-13	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075580 application number: ANDA075580
Doxazosin	DOXAZOSIN	Cardinal Health 107, LLC	08521333-ff21-45ad-b99e-1f43d945d24d	2026-04-24	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075580 application number: ANDA075580
Doxazosin	DOXAZOSIN	REMEDYREPACK INC.	30a6bb83-f91b-4c4f-a849-4f2be3735a0e	2026-04-14	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075580 application number: ANDA075580
Doxazosin	DOXAZOSIN	Preferred Pharmaceuticals Inc.	2110eec5-949d-4718-ad6d-3629e5db8a07	2026-04-08	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075580 application number: ANDA075580
Doxazosin	DOXAZOSIN	Preferred Pharmaceuticals Inc.	e046e0b7-f510-4318-9884-034d683864d4	2026-04-08	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075580 application number: ANDA075580
Doxazosin	DOXAZOSIN	AvPAK	de9ab9a4-d8b8-8b36-e053-2a95a90aaa35	2026-03-24	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075580 application number: ANDA075580
Doxazosin	DOXAZOSIN	AvKARE	e3d381c1-3b2f-af70-f4e6-08d6202eed25	2026-03-24	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075580 application number: ANDA075580
Doxazosin	DOXAZOSIN	NuCare Pharmaceuticals, Inc.	54116886-ea5e-5320-e054-00144ff8d46c	2026-02-16	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075580 application number: ANDA075580
Doxazosin	DOXAZOSIN	Bryant Ranch Prepack	54549d19-6311-4dbb-8622-fd3e5440551a	2026-01-29	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075580 application number: ANDA075580
Doxazosin	DOXAZOSIN	Northwind Health Company, LLC	f306adae-a2fe-5477-e053-2995a90a7838	2026-01-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075580 application number: ANDA075580
Doxazosin	DOXAZOSIN	American Health Packaging	3f4dc1a7-05e6-41d7-908c-30ce2677d87b	2025-09-17	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075580 application number: ANDA075580
Doxazosin	DOXAZOSIN	Apotex Corp.	4fa5c2f7-cda9-56cd-622f-b3d05dc7c94b	2025-09-17	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075580 application number: ANDA075580
Doxazosin	DOXAZOSIN	Major Pharmaceuticals	3354196f-bbcf-4bc5-94f6-e6e8e132acb1	2025-07-08	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075580 application number: ANDA075580
Doxazosin	DOXAZOSIN	Aphena Pharma Solutions - Tennessee, LLC	2e5cd8cb-7d43-e7af-e063-6294a90a310e	2025-02-17	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075580 application number: ANDA075580
Doxazosin	DOXAZOSIN	NuCare Pharmaceuticals, Inc.	505d3c4c-5506-72cc-e054-00144ff88e88	2024-07-09	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075580 application number: ANDA075580
Doxazosin	DOXAZOSIN	Proficient Rx LP	1d8ff659-8129-4dca-9e8f-13b97240d1e1	2024-06-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075580 application number: ANDA075580
Doxazosin	DOXAZOSIN	Aphena Pharma Solutions - Tennessee, LLC	f1dc70f6-4329-46da-8990-7bd6eec9d37d	2021-12-07	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075580 application number: ANDA075580
Doxazosin	DOXAZOSIN	Aphena Pharma Solutions - Tennessee, LLC	7e547752-a53a-4ad9-b70e-7cc2a1dd5d5d	2018-03-06	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075580 application number: ANDA075580

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
86P6PQK0MU	DOXAZOSIN MESYLATE	77883-43-3	DOXAZOSIN MESYLATE
NW1291F1W8	DOXAZOSIN	74191-85-8	Doxazosin

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
197625	doxazosin mesylate 1 MG Oral Tablet	PSN	bfea0b5b-9354-490f-88ff-008134077d24	30
197626	doxazosin mesylate 2 MG Oral Tablet	PSN	bfea0b5b-9354-490f-88ff-008134077d24	30
197627	doxazosin mesylate 4 MG Oral Tablet	PSN	bfea0b5b-9354-490f-88ff-008134077d24	30
197628	doxazosin mesylate 8 MG Oral Tablet	PSN	bfea0b5b-9354-490f-88ff-008134077d24	30
197625	doxazosin 1 MG Oral Tablet	SCD	bfea0b5b-9354-490f-88ff-008134077d24	30
197626	doxazosin 2 MG Oral Tablet	SCD	bfea0b5b-9354-490f-88ff-008134077d24	30
197627	doxazosin 4 MG Oral Tablet	SCD	bfea0b5b-9354-490f-88ff-008134077d24	30
197628	doxazosin 8 MG Oral Tablet	SCD	bfea0b5b-9354-490f-88ff-008134077d24	30
197625	doxazosin (as doxazosin mesylate) 1 MG Oral Tablet	SY	bfea0b5b-9354-490f-88ff-008134077d24	30
197626	doxazosin (as doxazosin mesylate) 2 MG Oral Tablet	SY	bfea0b5b-9354-490f-88ff-008134077d24	30
197627	doxazosin (as doxazosin mesylate) 4 MG Oral Tablet	SY	bfea0b5b-9354-490f-88ff-008134077d24	30
197628	doxazosin (as doxazosin mesylate) 8 MG Oral Tablet	SY	bfea0b5b-9354-490f-88ff-008134077d24	30

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
50090-0704-0	50090070400	30 TABLET in 1 BOTTLE (50090-0704-0)	30 tablet	2014-11-28	0000-00-00	No	No	Current
50090-0704-1	50090070401	100 TABLET in 1 BOTTLE (50090-0704-1)	100 tablet	2014-11-28	0000-00-00	No	No	Current